Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers

Gastric cancer (GC) is a deadly disease with limited treatment options. Recent studies with PD-1 inhibition have shown promising results in GC, but key questions remain regarding which GC subclass may respond best. In other cancers, expression of the PD-1 ligand PD-L1 has been shown to identify canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Derks, Sarah, Liao, Xiaoyun, Chiaravalli, Anna M., Xu, Xinsen, Camargo, M. Constanza, Solcia, Enrico, Sessa, Fausto, Fleitas, Tania, Freeman, Gordon J., Rodig, Scott J., Rabkin, Charles S., Bass, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078063/
https://www.ncbi.nlm.nih.gov/pubmed/27147580
http://dx.doi.org/10.18632/oncotarget.9076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078063/
https://www.ncbi.nlm.nih.gov/pubmed/27147580
http://dx.doi.org/10.18632/oncotarget.9076

Ejemplares similares